Fredgar AI Open SEC financial data — copy & download friendly

← All companies

PROCTER & GAMBLE CO

PG · CIK 0000080424 · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics

Financial snapshot

Revenue
21,235,000,000
USD · 2026-03-31
Cost of Revenue
10,722,000,000
USD · 2026-03-31
Operating Income
4,576,000,000
USD · 2026-03-31
Net Income
3,932,000,000
USD · 2026-03-31
Total Assets
128,378,000,000
USD · 2026-03-31
Total Liabilities
73,647,000,000
USD · 2026-03-31
Cash & Equivalents
9,304,000,000
USD · 2019-09-30

Financial statements

Income Statement — period ending 2026-03-31

Line itemValue (USD)Source filing
Revenue 65,828,000,000 0000080424-26-000060
Cost of Revenue 32,442,000,000 0000080424-26-000060

Balance Sheet — period ending 2026-03-31

Line itemValue (USD)Source filing
Accounts Receivable, Current 6,322,000,000 0000080424-26-000060
Inventory 7,853,000,000 0000080424-26-000060
Property, Plant & Equipment, Net 24,574,000,000 0000080424-26-000060
Accounts Payable, Current 15,030,000,000 0000080424-26-000060

Cash Flow Statement — period ending 2026-03-31

Line itemValue (USD)Source filing
Capital Expenditures 3,386,000,000 0000080424-26-000060

Derived metrics

Download CSV
MetricValueUnitPeriod end
capex_intensity 0.0514 ratio 2026-03-31
gross_margin 0.5072 ratio 2026-03-31
inventory_turns_sales_basis 8.3825 ratio 2026-03-31
sales_to_ppe 2.6788 ratio 2026-03-31
working_capital_proxy -8,708,000,000 USD 2026-03-31

Leadership (from SEC Forms 3/4/5)

Officers, directors, and ≥10% owners extracted from public SEC ownership filings. Tenure shown is a filing-date range (a proxy, not an official appointment record).

NameTitleRolesFirst seenLast seenNet insider shares
Portman Robert JonesDirectorDirector 2026-03-112026-06-10 739
Santos de Azevedo Juliana MonteiroCEO - GroomingOfficer 2026-07-102026-07-10 0
McEvoy AshleyDirectorDirector 2026-06-102026-06-10 1010
McCarthy Christine MDirectorDirector 2026-06-102026-06-10 1265
Kempczinski Christopher JDirectorDirector 2026-06-102026-06-10 1290
JIMENEZ JOSEPHDirectorDirector 2026-06-102026-06-10 1600
ARNOLD CRAIGDirectorDirector 2026-06-102026-06-10 1010
Abd El Hak HeshamCEO-Baby and Feminine CareOfficer 2026-06-082026-06-08 0
Gama PaulCEO- Health CareOfficer 2026-04-072026-04-07 0

Stakeholder orientation — people vs. profits (heuristic)

Index: -0.1901Balanced. Scale −1 (payout / shareholder-tilted) to +1 (reinvestment / stakeholder-tilted), period ending 2025-06-30.

SignalValueScoreWeightBasis
Reinvestment vs. shareholder payout -0.472 -0.472 0.4 +1 = all reinvested (capex+R&D); -1 = all paid to shareholders (buybacks+dividends).
Capex intensity (local-investment proxy) 0.0448 -0.1047 0.25 Proxy for building physical/local capacity. NOT a direct outsourcing measure.
R&D intensity 0.0249 -0.2508 0.2 R&D / revenue — investment in capability and people.
Insider alignment (net buy/sell) 6914.0 0.5 0.15 Directional 'skin in the game' signal from insider transactions.

Methodology & caveats: Heuristic model over public SEC XBRL facts. Signals describe capital allocation during the period, not the character, competence, or 'approval' of any individual. capex_intensity is a proxy for physical/local investment, NOT a direct measure of outsourcing/offshoring (which XBRL does not disclose). Verify against the original filings. Not investment, financial, or HR advice.

Filings (latest 50)

Download CSV
FormFiling datePeriodAccession
8-K 2026-07-14 2026-07-14 0000080424-26-000082
3/A 2026-07-10 2026-07-01 0000080424-26-000079
3 2026-07-10 2026-07-01 0000080424-26-000078
4 2026-06-10 2026-06-09 0000080424-26-000077
4 2026-06-10 2026-06-09 0000080424-26-000076
4 2026-06-10 2026-06-09 0000080424-26-000074
4 2026-06-10 2026-06-09 0000080424-26-000073
4 2026-06-10 2026-06-09 0000080424-26-000072
4 2026-06-10 2026-06-09 0000080424-26-000071
3 2026-06-08 2026-06-01 0000080424-26-000070
11-K 2026-06-04 2025-12-31 0000080424-26-000069
SD 2026-05-27 0000080424-26-000065
SCHEDULE 13G 2026-04-30 0002100119-26-000950
10-Q 2026-04-24 2026-03-31 0000080424-26-000060
8-K 2026-04-24 2026-04-24 0000080424-26-000057
8-K 2026-04-24 2026-04-24 0000080424-26-000056
8-K 2026-04-14 2026-04-14 0000080424-26-000048
3 2026-04-07 2026-04-01 0000080424-26-000044
SCHEDULE 13G/A 2026-03-27 0000102909-26-002031
4/A 2026-03-19 2026-03-10 0000080424-26-000034
4 2026-03-11 2026-03-10 0000080424-26-000033
4 2026-03-11 2026-03-10 0000080424-26-000032
4 2026-03-11 2026-03-10 0000080424-26-000031
4 2026-03-11 2026-03-10 0000080424-26-000030
4 2026-03-11 2026-03-10 0000080424-26-000029
4 2026-03-11 2026-03-10 0000080424-26-000028
4 2026-03-02 2026-02-27 0000080424-26-000026
4 2026-02-23 2026-02-19 0000080424-26-000025
144 2026-02-18 0000080424-26-000024
4 2026-02-17 2026-02-13 0000080424-26-000023
4 2026-02-13 2026-02-11 0000080424-26-000022
4 2026-02-13 2026-02-11 0000080424-26-000021
4 2026-02-13 2026-02-12 0000080424-26-000020
144 2026-02-13 0000080424-26-000019
144 2026-02-10 0000080424-26-000018
144 2026-02-10 0000080424-26-000017
144 2026-02-09 0000080424-26-000016
4 2026-02-04 2026-02-04 0000080424-26-000015
144 2026-02-03 0000080424-26-000014
144 2026-01-28 0000080424-26-000013
4 2026-01-26 2026-01-23 0000080424-26-000012
10-Q 2026-01-23 2025-12-31 0000080424-26-000011
144 2026-01-22 0000080424-26-000010
8-K 2026-01-22 2026-01-22 0000080424-26-000009
8-K 2026-01-22 2026-01-22 0000080424-26-000006
8-K 2026-01-13 2026-01-13 0000080424-26-000002
8-K 2025-12-15 2025-12-15 0000080424-25-000287
4 2025-12-10 2025-12-09 0000080424-25-000284
4 2025-12-10 2025-12-09 0000080424-25-000283
4 2025-12-10 2025-12-09 0000080424-25-000282

XBRL facts (showing 100 of 25529)

Download all 25529 facts (CSV)
ConceptTaxonomyPeriod startPeriod endUnitValue
AccountsPayableCurrentus-gaap 2026-03-31USD 15,030,000,000
AccountsReceivableNetCurrentus-gaap 2026-03-31USD 6,322,000,000
AccruedLiabilitiesCurrentus-gaap 2026-03-31USD 10,031,000,000
AccumulatedOtherComprehensiveIncomeLossNetOfTaxus-gaap 2026-03-31USD -12,298,000,000
AdditionalPaidInCapitalus-gaap 2026-03-31USD 69,375,000,000
AllocatedShareBasedCompensationExpenseus-gaap 2025-07-012026-03-31USD 394,000,000
AllocatedShareBasedCompensationExpenseus-gaap 2026-01-012026-03-31USD 132,000,000
AmortizationOfIntangibleAssetsus-gaap 2025-07-012026-03-31USD 232,000,000
AmortizationOfIntangibleAssetsus-gaap 2026-01-012026-03-31USD 76,000,000
Assetsus-gaap 2026-03-31USD 128,378,000,000
AssetsCurrentus-gaap 2026-03-31USD 27,987,000,000
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsus-gaap 2026-03-31USD 12,306,000,000
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectus-gaap 2025-07-012026-03-31USD 2,749,000,000
CashEquivalentsAtCarryingValueus-gaap 2026-03-31USD 11,100,000,000
CollateralAlreadyPostedAggregateFairValueus-gaap 2026-03-31USD 477,000,000
CommonStockDividendsPerShareDeclaredus-gaap 2025-07-012026-03-31USD/shares 3
CommonStockDividendsPerShareDeclaredus-gaap 2026-01-012026-03-31USD/shares 1
CommonStockSharesIssuedus-gaap 2026-03-31shares 4,009,200,000
CommonStockValueus-gaap 2026-03-31USD 4,009,000,000
ComprehensiveIncomeNetOfTaxus-gaap 2025-07-012026-03-31USD 12,847,000,000
ComprehensiveIncomeNetOfTaxus-gaap 2026-01-012026-03-31USD 3,742,000,000
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestus-gaap 2025-07-012026-03-31USD 45,000,000
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestus-gaap 2026-01-012026-03-31USD 11,000,000
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestus-gaap 2025-07-012026-03-31USD 12,892,000,000
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestus-gaap 2026-01-012026-03-31USD 3,753,000,000
CostOfGoodsAndServicesSoldus-gaap 2025-07-012026-03-31USD 32,442,000,000
CostOfGoodsAndServicesSoldus-gaap 2026-01-012026-03-31USD 10,722,000,000
DebtCurrentus-gaap 2026-03-31USD 13,174,000,000
DeferredIncomeTaxExpenseBenefitus-gaap 2025-07-012026-03-31USD 178,000,000
DeferredIncomeTaxLiabilitiesNetus-gaap 2026-03-31USD 6,047,000,000
DepreciationDepletionAndAmortizationus-gaap 2025-07-012026-03-31USD 2,348,000,000
DepreciationDepletionAndAmortizationus-gaap 2026-01-012026-03-31USD 785,000,000
DerivativeAssetsus-gaap 2026-03-31USD 88,000,000
DerivativeLiabilitiesus-gaap 2026-03-31USD 568,000,000
DerivativeNotionalAmountus-gaap 2026-03-31USD 19,348,000,000
DividendsCommonStockus-gaap 2025-07-012026-03-31USD 7,425,000,000
DividendsCommonStockus-gaap 2026-01-012026-03-31USD 2,465,000,000
DividendsPreferredStockus-gaap 2025-07-012026-03-31USD 218,000,000
DividendsPreferredStockus-gaap 2026-01-012026-03-31USD 72,000,000
EarningsPerShareBasicus-gaap 2025-07-012026-03-31USD/shares 5
EarningsPerShareBasicus-gaap 2026-01-012026-03-31USD/shares 2
EarningsPerShareDilutedus-gaap 2025-07-012026-03-31USD/shares 5
EarningsPerShareDilutedus-gaap 2026-01-012026-03-31USD/shares 2
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsus-gaap 2025-07-012026-03-31USD -94,000,000
EntityCommonStockSharesOutstandingdei 2026-03-31shares 2,328,598,978
FiniteLivedIntangibleAssetsAccumulatedAmortizationus-gaap 2026-03-31USD 7,189,000,000
FiniteLivedIntangibleAssetsGrossus-gaap 2026-03-31USD 9,175,000,000
GainLossOnDispositionOfAssets1us-gaap 2025-07-012026-03-31USD 345,000,000
Goodwillus-gaap 2026-03-31USD 41,359,000,000
GoodwillTranslationAndPurchaseAccountingAdjustmentsus-gaap 2025-07-012026-03-31USD -330,000,000
IncomeLossIncludingPortionAttributableToNoncontrollingInterestus-gaap 2025-07-012026-03-31USD 16,444,000,000
IncomeLossIncludingPortionAttributableToNoncontrollingInterestus-gaap 2026-01-012026-03-31USD 4,989,000,000
IncomeTaxExpenseBenefitus-gaap 2025-07-012026-03-31USD 3,381,000,000
IncomeTaxExpenseBenefitus-gaap 2026-01-012026-03-31USD 1,039,000,000
IncreaseDecreaseInAccountsPayableus-gaap 2025-07-012026-03-31USD 196,000,000
IncreaseDecreaseInAccountsReceivableus-gaap 2025-07-012026-03-31USD 186,000,000
IncreaseDecreaseInInventoriesus-gaap 2025-07-012026-03-31USD 346,000,000
IncrementalCommonSharesAttributableToConversionOfPreferredStockus-gaap 2025-07-012026-03-31shares 68,700,000
IncrementalCommonSharesAttributableToConversionOfPreferredStockus-gaap 2026-01-012026-03-31shares 68,000,000
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsus-gaap 2025-07-012026-03-31shares 21,800,000
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsus-gaap 2026-01-012026-03-31shares 20,000,000
IndefiniteLivedIntangibleAssetsExcludingGoodwillus-gaap 2026-03-31USD 19,544,000,000
IntangibleAssetsGrossExcludingGoodwillus-gaap 2026-03-31USD 28,719,000,000
IntangibleAssetsNetExcludingGoodwillus-gaap 2026-03-31USD 21,531,000,000
InterestExpenseNonoperatingus-gaap 2025-07-012026-03-31USD 641,000,000
InterestExpenseNonoperatingus-gaap 2026-01-012026-03-31USD 223,000,000
InventoryFinishedGoodsNetOfReservesus-gaap 2026-03-31USD 4,819,000,000
InventoryNetus-gaap 2026-03-31USD 7,853,000,000
InventoryRawMaterialsAndSuppliesNetOfReservesus-gaap 2026-03-31USD 1,971,000,000
InventoryWorkInProcessNetOfReservesus-gaap 2026-03-31USD 1,063,000,000
InvestmentIncomeInterestus-gaap 2025-07-012026-03-31USD 322,000,000
InvestmentIncomeInterestus-gaap 2026-01-012026-03-31USD 100,000,000
Liabilitiesus-gaap 2026-03-31USD 73,647,000,000
LiabilitiesAndStockholdersEquityus-gaap 2026-03-31USD 128,378,000,000
LiabilitiesCurrentus-gaap 2026-03-31USD 38,235,000,000
LongTermDebtFairValueus-gaap 2026-03-31USD 29,400,000,000
LongTermDebtNoncurrentus-gaap 2026-03-31USD 23,852,000,000
MinorityInterestus-gaap 2026-03-31USD 226,000,000
MinorityInterestPeriodIncreaseDecreaseus-gaap 2025-07-012026-03-31USD 90,000,000
MinorityInterestPeriodIncreaseDecreaseus-gaap 2026-01-012026-03-31USD 61,000,000
NetCashProvidedByUsedInFinancingActivitiesus-gaap 2025-07-012026-03-31USD -8,154,000,000
NetCashProvidedByUsedInInvestingActivitiesus-gaap 2025-07-012026-03-31USD -3,428,000,000
NetCashProvidedByUsedInOperatingActivitiesus-gaap 2025-07-012026-03-31USD 14,425,000,000
NetIncomeLossus-gaap 2025-07-012026-03-31USD 13,002,000,000
NetIncomeLossus-gaap 2026-01-012026-03-31USD 3,932,000,000
NetIncomeLossAttributableToNoncontrollingInterestus-gaap 2025-07-012026-03-31USD 60,000,000
NetIncomeLossAttributableToNoncontrollingInterestus-gaap 2026-01-012026-03-31USD 18,000,000
NetIncomeLossAvailableToCommonStockholdersBasicus-gaap 2025-07-012026-03-31USD 12,784,000,000
NetIncomeLossAvailableToCommonStockholdersBasicus-gaap 2026-01-012026-03-31USD 3,860,000,000
NumberOfReportableSegmentsus-gaap 2025-07-012026-03-31segment 5
OperatingIncomeLossus-gaap 2025-07-012026-03-31USD 15,798,000,000
OperatingIncomeLossus-gaap 2026-01-012026-03-31USD 4,576,000,000
OtherAssetsNoncurrentus-gaap 2026-03-31USD 12,928,000,000
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxus-gaap 2025-07-012026-03-31USD 1,000,000
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxus-gaap 2026-01-012026-03-31USD 1,000,000
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxus-gaap 2025-07-012026-03-31USD -58,000,000
OtherComprehensiveIncomeLossBeforeTaxus-gaap 2025-07-012026-03-31USD -43,000,000
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTaxus-gaap 2025-07-012026-03-31USD 191,000,000
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTaxus-gaap 2026-01-012026-03-31USD 56,000,000
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxus-gaap 2025-07-012026-03-31USD -186,000,000

Download data

Full profile (JSON)XBRL facts (CSV)Derived metrics (CSV)Statements (CSV)Filings (CSV)